Table 3 Treatment provided and outcome in the groups of patients treated with different dialysis modalities, IHD versus CRRT (n = 81)
Treatment given | Complications and outcome | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Group of patients | Ethanol, n (%) | Fomepizole, n (%) | Alkalinization, n (%) | HD start, hours | HD duration, hours | Folate therapy, n (%) | Complications, n (%) | ICU LOS, days | Survivors without sequelae | Survived with sequelae | Died, n (%) |
IHD (n = 41; 9F) | 28 (68%) | 13 (32%) | 24 (59%) | 2.5 ± 0.6 | 9.1 ± 2.4 | 31 (76%) | 11 (27%) | 4 (1–16) | 23 (56%) | 13 (32%) | 5 (12%) |
CRRT (n = 40; 8F) | 27 (68%) | 12 (30%) | 33 (83%) | 3.5 ± 0.9 | 45.7 ± 9.7 | 34 (86%) | 13 (33%) | 4 (1–22) | 10 (25%) | 15 (37.5%) | 15 (37.5%) |
Total (n = 81) | 55 (68%) | 25 (31%) | 57 (70%) | 3.0 ± 0.6 | 25.8 ± 6.3 | 65 (80%) | 25 (31%) | 4 (1–22) | 33 (40%) | 28 (35%) | 20 (25%) |
P IHD/CRRT | 0.939 | 0.868 | 0.018 | 0.084 | <0.001 | 0.289 | 0.576 | 0.703 | 0.004 | 0.584 | 0.008 |